Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-24 @ 9:08 PM
NCT ID:
NCT05742204
Eligibility Criteria:
Inclusion Criteria:
* CT screening results showed that the size of pulmonary nodules was more than 5mm
* No treatment related to pulmonary nodules/lung cancer (including surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy, interventional therapy, etc.)
* Complete clinical and imaging data
* Chest CT/ low-dose spiral CT reports can be provided in the last 3 months
* Voluntarily sign informed consent
Exclusion Criteria:
* There is a history of tumor
* Clinically uncontrolled active infections, such as acute pneumonia, tuberculosis, etc.
* Received any treatment related to pulmonary nodules, such as antibiotics and hormones, in the past 4 weeks
* Complicated with other tumors and serious diseases of the heart, liver, kidney, brain, blood and other systems
* Participated in other clinical trials within the last 3 months
* Combined with liver and kidney insufficiency, hypoproteinemia and other diseases affecting protein content
* You are pregnant or breastfeeding
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05742204
Study Brief:
Protocol Section:
NCT05742204